Ultralife Corporation (NASDAQ: ULBI) Files Amended 2025 Annual Report: Key Investor Takeaways

Overview

Ultralife Corporation has filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment includes critical disclosures previously omitted, covering executive compensation, beneficial ownership, corporate governance, and related party transactions. The amendment was necessary as the company did not file its proxy statement within the SEC’s 120-day deadline and therefore included all Part III information directly in this filing.

Key Financial and Corporate Data

• Market Capitalization: As of June 30, 2025, the market value of shares held by non-affiliates was approximately \$90.47 million.
• Shares Outstanding: 16,656,503 shares of common stock as of April 24, 2026.
• Stock Exchange: Common Stock trades on NASDAQ under the symbol ULBI.
• Filing Status: Ultralife is an “Accelerated Filer” and a “Smaller Reporting Company.”
• Audit Fees: Significant audit fees of \$983,331 for 2025 and \$1,194,028 for 2024, with total audit-related expenses reaching up to \$1,378,828 in 2025, reflecting increased audit activity, including acquisition audits.

Corporate Governance and Shareholder Communication

• Ultralife’s independent directors met in executive session four times in 2025, with robust processes for shareholders to communicate with the board and nominate directors.
• The company has established a comprehensive enterprise risk management framework, with the Board and committees actively overseeing risk—including financial and cybersecurity risks.
• A Code of Ethics for all employees and directors is in place, emphasizing ethical business conduct and compliance with securities laws, including a strict insider trading policy and restrictions on hedging company securities.

Executive Compensation

As a smaller reporting company, Ultralife provides scaled disclosure on executive pay. Key highlights:

• Chief Executive Officer (Mr. Manna): Less than 1% direct ownership; 90,501 stock options exercisable within 60 days as of April 24, 2026.
• Chief Financial Officer (Philip A. Fain): 137,809 shares held directly and 102,267 stock options exercisable within 60 days; total compensation in 2025 included \$370,142 in salary.
• Short-Term Incentive Plan (STIP): Target bonus levels for CEO and CFO were 60% and 50% of base salary, respectively, with a performance goal of \$18.5 million in consolidated operating profit for 2025.
• Long-Term Incentives: On December 13, 2024, the Board granted Mr. Fain options to purchase 15,000 shares, vesting over three years.
• Equity Compensation Plans: As of December 31, 2025, 967,351 shares were subject to outstanding options at a weighted-average exercise price of \$6.95, with 1,709,020 shares available for future grants.
• No Employment Contracts: Neither the CEO nor the CFO has an employment agreement; both are subject to standard confidentiality and non-compete agreements.

Beneficial Ownership and Insider Holdings

• Significant Shareholders: Dimensional Fund Advisors LP reported beneficial ownership of more than 5% of outstanding shares.
• Directors and Executives as a Group: Six persons collectively held 7,121,076 shares (42.3% of outstanding shares), indicating strong insider alignment with shareholders.
• Stock Options: The reported ownership includes shares that may be acquired via options exercisable within 60 days.

Related Party Transactions and Independence

• No Reportable Related Party Transactions: The company disclosed no related party transactions in 2025 or 2024, and none are currently proposed.
• Director Independence: A majority of the Board is independent, as per NASDAQ and SEC standards.

Potentially Price-Sensitive or Noteworthy Items for Investors

• Inclusion of Part III Disclosures: The delayed proxy statement and inclusion of all governance, compensation, and ownership disclosures in the 10-K/A may indicate heightened transparency or potential governance scrutiny.
• Large Insider Ownership: Management and directors own a significant portion (over 40%) of the company, which could impact strategic decisions, voting outcomes, and market perception.
• Recent Acquisition Activity: The 2024 acquisition of Electrochem Solutions, Inc. led to increased audit fees, indicating a potentially transformative deal for the company.
• Strong Controls and Risk Management: Investors should note the company’s focus on enterprise-wide risk management and robust governance mechanisms.
• No Material Related Party Transactions or Compensation Irregularities: The lack of restatements, error corrections, or related party issues suggests stable governance practices.

Conclusion

Ultralife Corporation’s 2025 10-K/A provides investors with a comprehensive overview of its governance, executive compensation, insider holdings, and risk management practices. With robust insider ownership, a focus on risk controls, and the absence of controversial related party transactions, the company demonstrates stability and alignment with shareholder interests. However, the recent significant acquisition and board-level transparency changes could influence future strategic direction and share price performance.

Disclaimer: This summary is for informational purposes only and does not constitute investment advice. Investors should read all official SEC filings and consult with a financial advisor before making investment decisions. The author is not responsible for any actions taken based on this content.

View ULTRALIFE CORP Historical chart here